Welcome to our dedicated page for Colgate Palmolive Co SEC filings (Ticker: CL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Colgate-Palmolive Company (NYSE: CL) SEC filings page on Stock Titan brings together the company’s regulatory disclosures, including Forms 10-K, 10-Q, 8-K and other documents filed with the U.S. Securities and Exchange Commission. These filings provide detailed information on Colgate-Palmolive’s Oral Care, Personal Care, Home Care and Pet Nutrition businesses, its financial performance and its capital structure.
Colgate-Palmolive’s 8-K filings illustrate how the company uses SEC reports to communicate material events. For example, an 8-K dated November 10, 2025 describes the execution of an underwriting agreement and the issuance of €600,000,000 of 3.250% Senior Notes due 2035 under an automatic shelf registration statement. Other 8-Ks furnish quarterly earnings press releases and explain multi-year productivity initiatives, such as the Strategic Growth and Productivity Program designed to support the company’s 2030 strategy by aligning its organizational structure, optimizing its global supply chain and streamlining overhead.
Filings also list Colgate-Palmolive’s securities registered under Section 12(b) of the Exchange Act, including its common stock (ticker CL) and various series of notes traded on the New York Stock Exchange. Through proxy statements and other periodic reports, investors can review topics such as segment reporting, non-GAAP financial measures like Base Business and organic sales growth, and risk factor disclosures.
On Stock Titan, these SEC documents are updated from EDGAR and paired with AI-powered summaries that highlight key points, such as changes in capital allocation, new debt offerings, productivity program charges or revisions to guidance. Users can quickly scan filings for material information while retaining access to the complete original documents for deeper analysis.
Colgate-Palmolive (NYSE: CL) submitted a routine Form 3 – Initial Statement of Beneficial Ownership for newly reported insider John Hazlin, Chief Growth Officer.
The filing shows Hazlin directly owns 14,385 common shares and indirectly owns 5,382 shares through the company’s 401(k) plan, for a total of 19,767 shares of common stock. In addition, he holds five separate stock-option grants covering an aggregate 103,340 underlying shares with exercise prices ranging from $72.83 to $106.34 and expiration dates between 2028 and 2032. Vesting schedules are disclosed for each grant, generally becoming exercisable in one-third increments starting one year after the grant date.
No purchases, sales or other transactions occurred on the reported event date (06/16/2025); the form simply establishes Hazlin’s beneficial ownership under Section 16(a). The filing contains no financial results, strategic updates, or other material corporate events.